Skip to main content

Post-IPO Equity Biotechnology Companies

Explore 481 biotechnology startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
481
Total Funding
$3.4B
Avg Funding
$134.6M
Cities
19

Export 481 Post-IPO Equity Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Carlton South, Australia
$2.9M
raised

Chimeric Therapeutics is a company developing ground-breaking CAR T cell therapies for solid tumors.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Sarasota, United States
$4.0M
raised

NAYA Biosciences is an agile and synergistic platform that provides access to the next generation of biotechnologies.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$3.9M
raised

Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, and oral kit inhibitor.

Jan 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$14.4M
raised

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

Dec 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom
$5.1M
raised

GENinCode is a genetic testing business specializing in the risk assessment and prediction of cardiovascular disease.

Dec 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
New York, United States
$20.1M
raised

IN8Bio is a biotechnology company focused on delivering a novel off-the-shelf product for the treatment of cancer.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Menlo Park, United States
$50.0M
raised

Personalis is a contract research organization and genome-scale diagnostics services company specializing in genome guided medicine.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Watertown, United States
$45.0M
raised

Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.

Dec 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Stockholm, Sweden
$674K
raised

Annexin Pharmaceuticals AB (publ) is a world-leading biotechnology company.

Dec 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Seattle, United States
$90.0M
raised

Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$30.0M
raised

CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$50.0M
raised

AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$1.2B
raised

EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.

Dec 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$224K
raised

RepliCel Life Sciences is a regenerative medicine company using cell therapy products for healing tendinosis, aging, and pattern baldness.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$172.4M
raised

Prothena is a clinical-stage neuroscience company focused on the discovery and development of novel therapies.

Dec 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Toronto, Canada
$1.6M
raised

PharmAla Biotech is a biotechnology company that provides manufacturing and sales of MDMA substances to the clinical research community.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Burlingame, United States
$201.0M
raised

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Richmond, United States
$115.0M
raised

BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.

Jan 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$350.0M
raised

Belite Bio is a clinical stage biopharmaceutical drug development company.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$19.8M
raised

Unlocking the next generation of biotech solutions.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 481 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Matawan, United States
$100.0M
raised

Apimeds Pharmaceuticals is a company that develops therapeutic application solutions for honeybee venom used for inflammatory conditions.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Irvine, United States
$238.0M
raised

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

Dec 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$1.3M
raised

IamFire is an investment firm that invests in a range of sectors like natural resource, life science and biotechnology.

Dec 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$550.0M
raised

Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$99.2M
raised

Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.

Dec 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 376 to 400 of 481 companies

Ready to Connect with Post-IPO Equity Biotechnology Startups?

Get verified founder emails, funding details, and company data for 481 post-ipo equity biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked